Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

LON/0NZT stock hub

LON/0NZT has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0NZTis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

38.5B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0NZT

In the news

Latest news · LON/0NZT

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E21.8

P25 n/aP50 n/aP75 n/a

Trailing P/E28.3

P25 n/aP50 n/aP75 n/a

ROE14.9

P25 n/aP50 n/aP75 n/a

ROIC15.8

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0NZT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

231

Groups with data

Currency

EUR

Showing 231 of 231 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Belgium
Country code	UK
Employees	9,765
Employees Change	-778%
Employees Change Percent	-8.3
Enterprise value	EUR 38.4B
Exchange	London Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Isin	BE0003739530
Last refreshed	2026-05-10
Market cap	EUR 38.5B
Price	EUR 234
Price currency	EUR
Rev Per Employee	691,555.41x
Sic	2836
Symbol	lon/0NZT
Website	https://www.ucb.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.53%
EV Earnings	28.25x
EV/EBIT	22.37x
EV/EBITDA	17x
EV/FCF	21.89x
EV/Sales	5.74x
FCF yield	4.56%
Forward P/E	21.77x
P/B ratio	4.06x
P/E ratio	28.32x
P/S ratio	5.7x
PE Ratio10 Y	34.96x
PE Ratio3 Y	31.83x
PE Ratio5 Y	46.54x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	25.67%
EBITDA Margin	33.77%
FCF margin	25.97%
Gross margin	74.29%
Gross Profit	EUR 5B
Gross Profit Growth	14.45%
Gross Profit Growth Q	29.51%
Gross Profit Growth3 Y	15.86%
Gross Profit Growth5 Y	9.66%
Net Income	EUR 1.4B
Net Income Growth	46.29%
Net Income Growth Q	26.37%
Net Income Growth3 Y	86.55%
Net Income Growth5 Y	33.03%
Pretax Margin	23.54%
Profit Margin	20.13%
Profit Per Employee	EUR 139,187
ROA	7
Roa5y	4.19
ROCE	14.44
ROE	14.91
Roe5y	9.64
ROIC	15.81
Roic5y	8.78

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	14.88%
Cagr15y	15.62%
Cagr1y	50.9%
Cagr3y	42.66%
Cagr5y	26.06%
Div CAGR10	3.38%
Div CAGR3	2.35%
Div CAGR5	2.51%
EPS Growth	46.53
EPS Growth Q	26.27
EPS Growth3 Y	87.31
EPS Growth5 Y	33.21
FCF Growth	99.41%
FCF Growth Q	89.69%
FCF Growth3 Y	44.95%
FCF Growth5 Y	20.4%
OCF Growth	84.46%
OCF Growth Q	82.66%
OCF Growth10 Y	9.86%
OCF Growth3 Y	37.1%
OCF Growth5 Y	16.95%
Revenue Growth	25.83x
Revenue Growth Q	26.57x
Revenue Growth3 Y	12.38x
Revenue Growth5 Y	7.96x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.44
Assets	EUR 15.8B
Cash	EUR 2.1B
Current Assets	EUR 5.2B
Current Liabilities	EUR 3.8B
Debt	EUR 2B
Debt EBITDA	EUR 0.86
Debt Equity	EUR 0.21
Debt FCF	EUR 1.12
Equity	EUR 9.5B
Interest Coverage	15.52
Liabilities	EUR 6.4B
Long Term Assets	EUR 10.6B
Long Term Liabilities	EUR 2.6B
Net Cash	EUR 102.9M
Net Cash By Market Cap	EUR 0.27
Net Debt EBITDA	EUR -0.05
Net Debt Equity	EUR -0.01
Net Debt FCF	EUR -0.06
Tangible Book Value	EUR 2B
Tangible Book Value Per Share	EUR 10.67
WACC	5.15

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.38
Inventory Turnover	1.42
Net Working Capital	EUR -565.3M
Quick ratio	0.94
Working Capital	EUR 1.4B
Working Capital Turnover	EUR 4.64

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.19%
Dividend Growth	5.5%
Dividend Growth Years	1%
Dividend per share	EUR 0.88
Dividend Years	20
Dividend Yield	0.38%
Ex Div Date	2026-05-04
Last Dividend	EUR 0.88
Payout Frequency	Annual
Payout Ratio	16.94%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	300.39%
1Y total return	50.86%
200-day SMA	236.9
3Y total return	190.4%
50-day SMA	252.1
50-day SMA vs 200-day SMA	50over200
5Y total return	218.3%
All Time High	289.5
All Time High Change	-18.85%
All Time High Date	2026-02-19
All Time Low	17.11
All Time Low Change	1,272.8%
All Time Low Date	2008-10-27
ATR	8.02
Beta	0.17
Ch YTD	-0.78
High	235.2
High52	289.5
High52 Date	2026-02-19
High52ch	-19.27%
Low	230
Low52	146.4
Low52 Date	2025-05-12
Low52ch	59.64%
Ma50ch	-6.81%
Price vs 200-day SMA	-0.82%
RSI	38.52
RSI Monthly	65.5
RSI Weekly	46.36
Sharpe ratio	1.2x
Sortino ratio	2.29
Total Return	0.57%
Tr YTD	-0.34
Tr15y	782.63%
Tr1m	-9.65%
Tr1w	3.22%
Tr3m	-9.96%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 1.7B
Operating Income Growth	63.4
Operating Income Growth Q	147.7
Operating Income Growth3 Y	59.36
Operating Income Growth5 Y	28.3
Operating margin	25.67

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	119,858,808%
Net Borrowing	-606,387,213.1
Shares Institutions	31.49%
Shares Qo Q	-0.07%
Shares Yo Y	-0.19%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 1.8B
Average Volume	115,198.4x
Bv Per Share	49.8
CAPEX	EUR -245.1M
Ch10y	263.4
Ch15y	642.2
Ch1m	-10.04
Ch1w	3.22
Ch1y	50.19
Ch3m	-10.35
Ch3y	185
Ch5y	206.4
Ch6m	2.58
Change	-0.53%
Change From Open	0.84
Close	234.9
Days Gap	-1.36
Depreciation Amortization	542,374,868.2
Dollar Volume	7,361,505.3
Earnings Date	2026-07-30
EBIT	EUR 1.7B
EBITDA	EUR 2.3B
EPS	EUR 7.01
F Score	8
FCF	EUR 1.8B
FCF EV Yield	4.57x
Financing CF	-1,059,060,702
Fiscal Year End	December
Founded	1,925
Goodwill	4,403,876,322.3
Graham Number	103.37394
Graham Upside	-55.77
Income Tax	EUR 230.3M
Investing CF	-339,353,058
Is Primary Listing	0
Last Earnings Date	2026-02-26
Last Report Date	2025-12-31
Lynch Fair Value	EUR 206
Lynch Upside	-11.73
Ma150	249.1
Ma150ch	-5.69%
Ma20	246.3
Ma20ch	-4.63%
Net CF	591,468,827
Next Earnings Date	2026-07-30
Open	231.8
P FCF Ratio	21.95
P OCF Ratio	19.26
Payment Date	2026-05-06
Position In Range	71.27
Ppne	1,656,535,682
Price Date	2026-05-08
Price EBITDA	EUR 16.88
Ptbv Ratio	18.95
Relative Volume	0.27x
Revenue	6,753,038,627x
SBC By Revenue	-0.13x
Share Based Comp	-8,723,729
Tax By Revenue	3.41x
Tax Rate	14.49%
Tr6m	3.03%
Volume	31,499
Z Score	4.58

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

LON/0NZT dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.4%

$0.88 annual per share

Payout ratio

+16.9%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+2.5%

1 consecutive years of growth

Total shareholder yield

+0.6%

Next ex-dividend date: 2026-05-04

Performance

LON/0NZT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0NZT?

Insider, institutional, and short-interest positioning.

Institutional ownership

+31.5%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.2%

Negative means the company is buying back shares.

Technical

LON/0NZT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

38.5

Neutral momentum band

Price vs 200-day MA

-0.8%

50/200-day relationship not available

Beta (5Y)

0.17

Less volatile than the market

Sharpe ratio

1.20

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0NZT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0NZT stock rating?

lon/0NZT is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0NZT analysis?

The full report lives at /stocks/lon/0NZT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0NZT?

The latest report frames lon/0NZT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0NZT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.